CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Resident Rights
(Tag F0550)
Could have caused harm · This affected 1 resident
Based on observation, interview, and record review it was determined that the facility failed to provide a homelike and dignified dining experience to residents on 2 of 2 nursing units on 3 consecutiv...
Read full inspector narrative →
Based on observation, interview, and record review it was determined that the facility failed to provide a homelike and dignified dining experience to residents on 2 of 2 nursing units on 3 consecutive days. The deficient practice was evidenced by the following.
The surveyor observed the lunchtime meal at the following locations and days/times:
Second floor dining room - 8/28/23 at 12:00 PM; 8/29/23 at 12:17 PM; 8/30/23 at 11:57 AM.
Third floor dining room - 8/28/23 at 11:45 AM; 8/29/23 at 12:19 PM; 8/30/23 at 12:00 PM.
During each of the observations, staff served residents' meals on plastic trays. The trays remained in place throughout the residents' mealtime. Additionally, staff placed each plate dome lid upside down on residents' tables and used them as a trash container for wrappers and debris from the meal tray. The dome lids remained in place on the tables throughout the mealtime.
On 8/30/23 at 12:02 PM the surveyor interviewed the Licensed Practical Nurse (LPN) who supervised the second floor dining room. The LPN stated it was the practice of the facility to leave meal plates on the plastic trays and to leave the dome lids on the table during the entire dining period.
On 8/30/23 at 1:26 PM the surveyor told the Director of Nursing (DON) and the Administrator of observed concerns with dining practices that were not homelike or dignified.
On 8/31/23 at 10:05 AM the DON stated to the surveyor leaving plates on plastic serving trays and using dome lids for trash was a dignity concern.
On 9/6/23 the DON provided the surveyor with the facility Policy and Procedure for Meal Service, last reviewed 1/10/23. The document did not contain information for steps to set up the meal in a dignified and homelike manner.
NJAC 8:39-4.1(a)12
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Assessment Accuracy
(Tag F0641)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. Resident #254 was admitted on [DATE]. The Comprehensive/5 Day MDS had an ARD of 8/16/23 which was completed late on 8/30/23.
...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. Resident #254 was admitted on [DATE]. The Comprehensive/5 Day MDS had an ARD of 8/16/23 which was completed late on 8/30/23.
On 8/31/23 at 2:00 PM, a Validation Report was received from the Regional MDS Coordinator which confirmed the comprehensive assessment was completed late.
On 8/31/23 at 2:05 PM, the survey team spoke to the Director of Nursing (DON) and the Administrator regarding late MDS submissions. The DON stated a new MDS Coordinator was hired, however, did not show up for work. A second was hired but has not yet started.
The DON stated a Quality Assurance Performance Improvement (QAPI) was started in April 2023 for the timely completion of MDS assessments. The DON voluntarily provided information to the survey team regarding the facility's quarterly QAPI meetings and the MDS submission compliance rates.
The surveyors reviewed the facility's QAPI for Timely MDS Completion/Transmission, reporting period April 2023 to July 2023; reviewed 7/28/23 and 8/23/23; next review date 9/29/23. The April 2023 compliance rate of 95.7% had dropped to 31.2% in July 2023.
The DON provided the surveyors with the facility MDS policy on 8/31/23. Procedure #4 indicated the RN MDS Coordinator monitors the completion of the scheduled assessments including the Care Area assessments, signs and dates when the MDS is completed.
NJAC 8:39-11.2(e)
3. On 08/28/23 at 11:26 AM, the surveyor observed Resident #89, awake, alert lying in bed, responding to the surveyor by nodding his head.
The surveyor reviewed the medical records of Resident #89, which revealed the following:
Resident #89 was admitted to the facility on [DATE] and readmitted with diagnoses that included but were not limited to Acute and Chronic Respiratory Failure and Dysphagia (difficulty in swallowing).
The admission MDS (AMDS), dated [DATE], reflected that the resident had a Brief Interview for Mental Status (BIMS) score of 3 out of 15, indicating that the resident's cognition is severely impaired.
Resident #89 was observed to have an AMDS with an ARD of 3/22/2023 and was due to be submitted no later than 4/04/2023. The MDS was not submitted until 4/06/2023.
4. Resident #100 was admitted to the facility on [DATE] with diagnoses that included but were not limited to Type 2 diabetes mellitus (increased sugar level) with diabetic chronic kidney disease.
The AMDS, dated [DATE], reflected that the resident had a BIMS score of 13 out of 15, indicating that the resident's cognition is intact.
Resident #100 was observed to have an AMDS with an ARD of 7/24/2023 and was due to be submitted no later than 8/06/2023. The MDS was not submitted until 8/23/2023.
Based on interview and record review, it was determined that the facility failed to complete quarterly and comprehensive Minimum Data Set (MDS) assessments in a timely manner for 5 of 23 residents reviewed (Resident #8, #39, #89, #100 and #254). The MDS is an assessment tool used to guide the resident's plan of care.
This deficient practice was evidenced by the following:
1. On 8/30/23 the surveyor reviewed the MDS Summary for Resident #8 which revealed the following.
The annual MDS indicated an observation end date or assessment reference date (ARD) of 7/21/23. The status of the annual MDS was listed as in progress.The MDS should have been completed by the 14th day (8/4/23). The MDS was 26 days overdue on the day of the surveyor's record review (8/30/23).
2. On 8/30/23 the surveyor reviewed the MDS Summary for Resident #39 which revealed the following.
The quarterly MDS indicated an ARD of 7/21/23. The status of the quarterly MDS was listed as in progress. The MDS should have been completed by the 14th day (8/4/23). The MDS was 26 days overdue on the day of the surveyor's record review (8/30/23).
CONCERN
(D)
📢 Someone Reported This
A family member, employee, or ombudsman was alarmed enough to file a formal complaint
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected 1 resident
Complaint # NJ00155894
Based on interviews, review of medical records and other facility documentation, it was determined that the facility failed to develop a comprehensive, person-centered Care Plan...
Read full inspector narrative →
Complaint # NJ00155894
Based on interviews, review of medical records and other facility documentation, it was determined that the facility failed to develop a comprehensive, person-centered Care Plan (CP) to address the needs for a resident with Diabetes, Epilepsy (a disorder that causes seizures), and that required oxygen (Resident #104), 1 of 24 residents reviewed for CP.
This deficient practice was evidenced by the following:
According to the admission Record, Resident #104 was admitted to the facility in May of 2022, with diagnoses that included but were not limited to: traumatic subdural hemorrhage (caused by a blow to the head or fall, causing bleeding inside the brain), Epilepsy, dependence on supplemental oxygen, and Type 2 Diabetes Mellitus.
A review of the admission Minimum Data Set (MDS), an assessment tool dated 5/10/22, revealed a Brief Interview for Mental Status of 00 indicating severe cognitive impairment. Further review of the MDS revealed the resident was total dependence for activities of daily living, had an Active Diagnoses of Diabetes Mellitus, Seizure Disorder or Epilepsy, Respiratory Failure, and dependence of supplemental oxygen.
A review of the physician order summary report for May 2022 revealed a physician's order for OXY* Oxygen inhalation (via nasal cannula @-2 lpm (liters per minute)) every shift check every shift; Keppra Tablet 500 MG (milligrams) (levETIRAcetam) give 1 tablet via G-tube two times a day for seizures; HumaLOG Solution 100 unit/ML (milliliters) (Insulin Glargine) inject as per sliding scale . subcutaneously every 6 hours for dm (diabetes); Lantus Solution 100 unit/ML (Insulin Glargine) inject 10 unit subcutaneously at bedtime for dm.
A review of the facility provided CP initiated 05/07/22, revealed a Focus for Resident #104; at risk for falls r/t (related to) impaired safety awareness, impaired mobility. Combative behavior. Hx (history) of repeated falls w/ subdural hematoma .Date Initiated: 05/07/2022. Further review of the CP, did not reveal a Focus for epilepsy, Type 2 Diabetes, or supplemental oxygen use.
On 08/31/23 at 1:21 PM, during an interview with the surveyors, the Licensed Practical Nurse (LPN) stated that the purpose of the CP was to know what the resident's goals were and what the resident was capable of doing. She then stated that the focus of the CP was guided toward the resident's diagnoses. The surveyor asked the LPN if she would expect to see a CP for a resident with diagnoses of Diabetes, Epilepsy, and oxygen use, she stated, yes, they should all be on the CP.
On 09/01/23 at 9:28 AM, during a meeting with the surveyor, the Director of Nursing (DON) and the Assistant Director of Nursing (ADON), the DON stated that the purpose of the CP was to actually meet the needs of the patient and to makes sure the interdisciplinary team, the patient and the responsible party were on same page. The DON stated that it would include the MDS and medical diagnoses. The surveyor asked the DON and the ADON, if they would expect to see a CP for a resident with diagnoses of Diabetes, Epilepsy, and oxygen use, they both stated, yes they should. The surveyor asked the DON and the ADON to review the facility provided CP, for resident #107, for Diabetes, Epilepsy, and/or oxygen use. The DON stated, sad to say, I cannot find those 3 items. They both confirmed that all 3 of the above items should have been addressed on the CP.
A review of the facility's policy Comprehensive Care Plan with a last review date of 2/1/23, revealed:
Policy Statement:
A. A comprehensive care plan for each resident shall be developed and initiated on admission at this facility utilizing and interdisciplinary team approach. The comprehensive care plan will be individualized, defining the problems/needs identified from each discipline's assessment, attainable goals, and interventions.
B. The resident's initial comprehensive care plan shall be completed by all disciplines within 14 days of admission.
Purpose:
A. To provide a system for all disciplines involved to direct resident care to: Identify and assess each resident's problems/needs. Develop, document, and implement a coordinated plan of care. Evaluate the effectiveness of the plan of care and modify plan as needed.
N.J.A.C 8:39-11.2 (d) (e) (1) (2) (3)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Respiratory Care
(Tag F0695)
Could have caused harm · This affected 1 resident
Based on observation, interview, and record review it was determined that the facility failed to ensure a physician's order for oxygen therapy was complete and thorough for 1 (#254) of 1 resident revi...
Read full inspector narrative →
Based on observation, interview, and record review it was determined that the facility failed to ensure a physician's order for oxygen therapy was complete and thorough for 1 (#254) of 1 resident reviewed for respiratory services.
The deficient practice was evidenced by the following:
On 8/29/23 at 9:30 AM, the surveyor observed resident #254 in his/her room awake, alert, and oriented in bed. The oxygen concentrator was turned off and had no tubing or nasal cannula attached. The water reservoir was dated 8/26/23.
On 08/30/23 at 11:53 AM, the surveyor interviewed the resident. The resident was pleasant and interviewable. The oxygen concentrator at the bedside was turned off and had no tubing or nasal cannula attached.
On 08/30/23 12:15 PM, the surveyor interviewed the Licensed Practical Nurse (LPN) assigned to the resident. The surveyor asked the LPN to review the oxygen order with her in the Electronic Health Record (EHR). The LPN showed the surveyor the order which read Oxygen Inhalation (via nasal cannula @ 2 lpm [liters per minute]) every shift check every shift, Start Date 08/26/2023 0700. The LPN confirmed the order was incomplete since it did not indicate whether the oxygen was to be used continuously or as needed (prn).
A review of the hybrid Medical Record revealed the following information.
The August 2023 Order Summary included an order for oxygen therapy as follows. - OXY* Oxygen Inhalation (via nasal cannula @ 2 lpm) every shift check every shift, Start Date 08/26/2023 0700.
The respiratory Care Plan initiated on 8/28/23, included an intervention for oxygen settings O2 via nasal cannula @ 2 lpm.
On 8/30/23 at 1:30 PM, the surveyor interviewed the Administrator, Director of Nursing (DON), Assistant Director of Nursing (ADON) and Infection Preventionist (IP) regarding the incomplete oxygen order.
On 08/31/23 at 10:00 AM, the DON confirmed the oxygen order was incomplete. A new oxygen order was received from the physician on 8/30/23 for 2 lpm as needed for low oxygen level.
On 8/31/23 the DON provided the surveyor with the facility Oxygen Administration Policy and Procedure with a reviewed date of 10/29/22. The policy reflected that if a resident is using oxygen, the frequency and duration of the treatment should be recorded in the resident's medical record.
NJAC 8:39-27.1(a)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Unnecessary Medications
(Tag F0759)
Could have caused harm · This affected 1 resident
Based on observation, interview, and record review, it was determined that the facility failed to ensure that all medications were administered without error of 5% or more. During the medication obser...
Read full inspector narrative →
Based on observation, interview, and record review, it was determined that the facility failed to ensure that all medications were administered without error of 5% or more. During the medication observation on 8/30/23, the surveyor observed two (2) nurses administer medications to five (5) residents. There were 31 opportunities, and six (6) errors were observed which calculated to a medication administration error rate of 19.3%. This deficient practice was identified for two (2) of five (5) residents, (Resident #56 and #83), that were administered medications by one (1) of two (2) nurses that were observed.
The deficient practice was evidenced by the following:
1. On 8/30/23 at 8:00 AM, during the morning medication pass, the surveyor observed the Licensed Practical Nurse (LPN #1) obtaining a blood pressure (BP) for Resident #56. The LPN#1 placed the BP cuff on the resident's right leg below the knee. The LPN #1 stated that this was the best way to obtain the BP because the resident was very thin. The LPN#1 then stated that she received an error indication on the digital BP machine, the surveyor observed her reposition the BP cuff on the same area and immediately restarted the BP machine. The LNP#1 then stated that she had obtained a BP of 187/147 and a heart rate (HR) of 63. The LPN#1 added that the resident's BP was usually high and would check the BP again later.
After removing the BP cuff, the LPN#1 asked the resident if he/she wanted the Iron pill and the resident shook their head in the yes direction. The LNP#1 explained to the surveyor that the resident did not always like the Iron pill because it turned the applesauce black and would refuse to take it.
On 8/30/23 at 8:07 AM, the surveyor observed the LPN#1 preparing five (5) medications which included one (1) 20 milligram (MG) tablet of Famotidine (Pepcid) (a medication used to treat excess stomach acid), one (1) 100 MG tablet of Metoprolol Tartrate (Lopressor)(a medication used to slow the HR and lower the BP), one (1) 150 MG capsule of Polysaccharide-Iron Complex (Ferrex)(a medication used to treat iron deficiency), one (1) 500 MG tablet of Ascorbic Acid (Vitamin C)(a supplement) and two (2) 325 MG tablets of Acetaminophen (Tylenol)(a medication used for pain relief) for Resident #56.
On 8/30/23 at 8:14 AM, the surveyor observed the LPN #1 crush four (4) of the five (5) medications together in a pouch and then poured the crushed medications into a 30 milliliter (ML) medication cup with applesauce. The LPN#1 then opened the Ferrex capsule and mixed the contents into the medication cup that had the four (4) medications and filled the medication cup with applesauce. The applesauce then turned a black color.
On 8/30/23 at 8:16 AM, the surveyor observed the LPN#1 approach the resident to administer the five (5) medications in the applesauce and the resident was shaking their head in the no direction. The LPN #1 explained that the applesauce contained the resident's medication and that it was important to take the medications. The LPN#1 scooped a spoonful of the applesauce and administered the spoonful to the resident. The resident took the spoonful and shook their head in the no direction repeatedly. The LPN#1 explained again the importance and told the resident there was just another spoonful left. The LPN#1 was unable to administer the remaining applesauce containing the medications.
Upon returning to the medication cart, the LPN#1 discarded the remaining applesauce and stated that the resident had swallowed more than half of the applesauce, so she felt that the resident had received the medications. The LPN#1 then indicated on the electronic administration record (EMAR) that the resident had received the five (5) medications.
At that time, the LPN#1 was unable to verify that the complete dose of each of the five (5) medications was received. The LPN#1 stated that she should have used less applesauce. (ERROR #1, #2, #3, #4, #5)
The surveyor reviewed the medical record for Resident #56.
A review of the resident's admission Record (AR) revealed diagnoses which included dysphagia (difficulty swallowing), aphasia (difficulty speaking), hypertension (HTN)(high blood pressure), severe protein-calorie malnutrition and gastro-esophageal reflux disease (acid reflux).
A review of the quarterly Minimum Data Set (MDS), an assessment tool used to facilitate the management of care, with an assessment reference date of 7/14/2023, reflected the resident had a brief interview for mental status (BIMS) score of three (0) out of 15, indicating that the resident had a severely impaired cognition.
A review of the Order Summary Report revealed physician orders (PO) for the following:
Famotidine tablet 20 MG, give 1 tablet by mouth in the morning for acid indigestion with a start date 1/13/23.
Metoprolol Tartrate oral tablet 100 MG, give one tablet by mouth two times a day for HTN-give with food hold if systolic BP less than 110 millimeter of mercury (mmhg) and HR less than 60 with a start date of 7/25/23.
Polysaccharide Iron Complex capsule 150 MG, give 1 capsule by mouth one time a day for deficiency with a start date of 1/13/23.
Ascorbic Acid tablet 500 MG, give 1 tablet by mouth one time a day for supplement with a start date of 1/13/23.
Acetaminophen tablet 325 MG, give 2 tablet by mouth every 6 hours as needed for pain with a start date of 2/24/23.
A review of the EMAR revealed consistency with the above POs.
On 8/30/23 at 12:13 PM, the surveyor interviewed the Director of Nursing (DON) who stated that the Infection Preventionist (IP) and Assistant Director of Nursing (ADON) were the staff educators for medication pass.
On 8/30/23 at 1:08 PM, the surveyor interviewed the Unit Manager (UM)/LPN who stated that when the nurses had to crush medications that they should be crushed individually. The UM/LPN also stated that if crushed medications were all mixed in the same applesauce or pudding then the resident had to take the entire contents. The UM/LPN added stated that if the resident refused to finish the applesauce or pudding that contained all the medications then there was no way to know how much of the medications that the resident received. The UM/LPN stated that a BP of 187/147 had not sounded accurate and would retake the BP to be sure. The UM/LPN added that if the BP of 187/147 was a true reading than the physician should be called. The UM/LPN added that she would not administer any medication if she had not thought the BP was accurate.
On 8/31/23 09:30 AM, the surveyor interviewed the IP who stated that she was employed at the facility approximately less than two (2) months and could speak to medication pass techniques because she helped with orientation and educating the nurses on medication pass techniques. The IP stated that the nurses should not crush all the medications together because if the resident were to refuse to take all the applesauce or pudding that the medications were mixed in then there would be no way to determine which medication the resident had not received. The IP added that if a resident took some of the crushed medication there was no way to determine the actual dose received. The IP added that the nurse would have to document that the medication was refused because the whole dose would not have been administered and the physician should be notified. The IP also stated that the nurses should try to figure out why the resident was refusing medications and put interventions in place such as changing the medication if the taste were an issue or possibly changing the time. The IP then stated that crushing medications required a physician's order and usually would populate in the EMAR to crush the medications so that all the nurses were aware. In addition, the IP stated that a BP of 187/147 had not sounded accurate and would recommend retaking the BP and if the BP was accurate than the physician should be called.
On 8/31/23 at 11:30 AM, the IP provided the surveyor with an example of an unsampled residents electronic record that indicated Special Instructions: crush meds per resident request to explain how there was a section to populate that indicated that the resident took their medications crushed. A review of Resident #56's electronic record had not indicated special instructions.
In addition, the IP provided the surveyor with a Medication Pass Audit Tool dated 5/2/23 for LPN #1 completed by the Consultant Pharmacist (CP) which revealed that there were areas indicating a No, which meant that the technique was not performed appropriately, which included for the Technique Assessment: Medications via Gastric Tube that Administers each medication individually. was not performed correctly and there was a handwritten note that this was discussed.
On 8/31/23 at 2:07 PM, the survey team met with the Licensed Nursing Home Administrator (LNHA), DON, ADON and IP to review the medication observation results. The IP stated that when a medication pass audit was performed if there were indications that proper procedures were not followed then another observation and in servicing would be followed up. The DON stated that she would check if there were any other medication observations performed for LPN #1.
On 9/1/23 at 8:58 AM, the DON provided the surveyor with an In-service on medication pass dated 5/10/23 completed by the ADON and signed by LPN #1 was performed and a Competency Validation: Medication Pass was completed by the ADON on 7/26/23 that indicated the LPN#1 Meets Standard for all the Performance Criteria. In addition, the DON provided a Medication Observation Form dated 6/9/23 for LPN #1 completed by the provider pharmacy which revealed that there was zero (0) % error rate.
On 9/1/23 at 9:38 AM, the surveyor interviewed the Consultant Pharmacist (CP) via telephone who stated that she had been the consultant for the facility for approximately a year. The CP stated that she had performed medication observations with the nurses and verified that she used a Medication Pass Audit Tool but was unable to speak to the actual form that she had completed for LPN#1. The CP stated that she would add to the form Discussed tips & tricks for med pass observation by Department of Health (DOH), etc. because as she performed the medication observation, she would review different areas to help the nurses understand what the correct procedure that should be done during the medication pass. The CP stated that medications should be crushed separately unless there was a PO and the reason for crushing the medications separately was because if a resident refused to finish the vehicle that the medications were mixed in then the nurse would have no way of knowing the actual dose the resident received. The CP added that if a resident was refusing a medication or was unable to receive the entire dose then the physician should be notified, and the nurses should review the possible reason the resident was refusing to possibly make a change. The CP added that the completed Medication Pass Audit Tool was left with the DON and if there were issues, she would review them, and the DON would decide the next step.
A review of the facility policy dated as reviewed 6/22/23 for Medication Administration and Documentation provided by the DON reflected that The EMAR is the form onto which all medication orders are transcribed from physician electronic orders, from which medications are poured and administered and on which medication doses are documented. In addition, the policy reflected, Obtains orders for crushing of medications as appropriate/necessary as per manufacturer's directions and crushes medications individually prior to administration. Also, Administers full dose of medication to resident via correct route.
2. On 8/30/23 at 8:20 AM, during the morning medication pass, the surveyor observed the LPN #1 preparing six (6) medications which included a Lidocaine 5 % patch for Resident #83. The LPN#1 removed a Lidocaine 5% patch from the medication cart and stated that the patch was a house stock medication, meaning that the facility provided the medication and was an over the counter (OTC) medication.
On 8/30/23 at 8:35 AM, the surveyor observed the LPN#1 apply the Lidocaine 5% patch to the resident's right shoulder.
On 8/30/23 at 8:41 AM, upon returning to the medication cart, the surveyor with the LNP#1 reviewed the EMAR regarding the Lidocaine PO. The surveyor asked the LPN#1 if the PO on the EMAR for Aspercreme (Lidocaine) Patch 4% was the same as the Lidocaine 5% patch that she had applied to the resident's right shoulder. The LPN#1 stated that she thought the Lidocaine was a house stock medication and thought she was correct. The LPN#1 then looked in the medication cart and removed the box that she had taken the Lidocaine 5% patch from. The surveyor with the LPN#1 observed a label on the Lidocaine 5% patch box which revealed the name of an unsampled resident. The LPN#1 stated that the Lidocaine patch that she had removed was from the unsampled resident's box of Lidocaine 5% and thought there was another box that contained the house stock Lidocaine 4% patches. The LPN#1 looked through the medication cart and was unable to find a box containing Lidocaine 4% patches. The LPN#1 stated that she would have to call the physician. (ERROR #6)
The surveyor reviewed the medical record for Resident #83.
A review of the AR revealed that the resident had diagnoses which included adhesive capsulitis of unspecified shoulder (frozen shoulder).
A review of the admission MDS, an assessment tool used to facilitate the management of care with an assessment reference date of 6/23/2023, reflected the resident had a BIMS score of 15 out of 15, indicating that the resident had an intact cognition.
A review of the Order Summary Report revealed a PO dated 8/23/23 with for Aspercreme Lidocaine Patch 4% (Lidocaine), apply to Right shoulder topically one time a day for pain apply for 12 hours then remove.
A review of the EMAR revealed a PO with a start date of 8/24/23 for Aspercreme Lidocaine Patch 4% (Lidocaine), apply to Right shoulder topically one time a day for pain apply for 12 hours then remove.
On 8/30/23 at 12:11 PM, the DON provided the surveyor with the facility Over the Counter (OTC) List. The DON explained that the list indicated which medications the provider pharmacy would know not to send to the facility if there was a PO and the facility would provide.
A review of the OTC List reflected for Lidocaine/Asper 4% that the provider pharmacy Do NOT Send and that the facility provided that medication.
On 8/30/23 at 12:13 PM, the DON stated that a med error report for Resident #86 was done. The DON acknowledged that Aspercreme (Lidocaine) 4% was a house stock medication and was ordered for Resident #83 and that the LPN#1 had administered Lidocaine 5% that was obtained from an unsampled resident's prescription. The DON added that the physician was notified.
A review of the facility policy dated as reviewed 6/22/23 for Medication Administration and Documentation provided by the DON reflected that Assures the 5 rights: Compares the medication name, strength, route and dosage schedule on the medication administration record against the prescription label, Always check three times prior to administration of medication.
NJAC 8:39-11.2(b), 27.1(a), 29.2(a)(d)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0761
(Tag F0761)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. On [DATE] at 01:33 PM, ADON/RN (Nurse #1) told the surveyors she was ready to do the treatment pass. The treatment cart was r...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. On [DATE] at 01:33 PM, ADON/RN (Nurse #1) told the surveyors she was ready to do the treatment pass. The treatment cart was right outside the resident's room, and there was a computer on top of the treatment cart. The Nurse #1 read the following treatment: Mupirocin External Ointment 2 % (Mupirocin) Apply to sacrum topically every day shift for wound care clean with NSS, apply santyl, bactroban (mupirocin), pack with gauze, cover with foam dressing AND Apply to sacrum topically as needed for wound care for 30 Days clean with NSS, apply santyl, bactroban (mupirocin), pack with gauze, cover with foam dressing.
On [DATE] at 01:37 PM, the Nurse #1 squeezed Santyl into the two (2) medicine cups and one (1) medicine cup for Bactroban cream, then checked the order from the computer.
On [DATE] at 01:47 PM, the Nurse #1 entered the resident's room, put on gloves, and put the treatment supplies on the overbed table. Nurse #1 returned to the treatment cart to get the two medicine cups that contained Bactroban and Santyl in each cup outside the resident's room. The Nurse #1 returned to the resident's room but left one medicine cup with Santyl on top of the treatment cart outside. The surveyor got the attention of the Nurse #1 regarding the medication left on top of the treatment cart. The Nurse #1 stated that she forgot but did not comment further.
NJAC: 8:39-29.4 (a) (h) (d)
Based on observation, interview, and record review, it was determined that the facility failed to (a). properly label, store and dispose of medications in two (2) of five (5) medication carts inspected, b). failed to secure two (2) of two (2) narcotic lock boxes in 2 of 2 medication refrigerators inspected, and c). failed to secure medications in one (1) of five (5) and in one (1) of four (4) treatment carts observed.
This deficient practice was evidenced by the following:
a). On [DATE] at 11:10 AM, the surveyor inspected the 3rd floor medication cart A in the presence of Licensed Practical Nurse (LPN#1). The surveyor observed an unopened and undated bottle of Xalatan eye drops (medication for pressure in the eyes), an opened bottle of Xalatan eye drops with an opened date of [DATE] with an expiration date of [DATE], and an opened bottle of Dorzolamide eye drops (pressure in the eyes) with an opened date of [DATE] and was expired.
The surveyor interviewed LPN#1 who stated that both Xalatan and Dorzolamide were outdated and should have been removed from the medication cart. LPN#1 also stated that a bottle of unopened and undated Xalatan eye drops should have been stored in the medication refrigerator.
On [DATE] at 11:20 AM, the surveyor inspected the 3rd floor medication cart B in the presence of LPN#2. The surveyor observed an opened and undated bottle of LPS (protein supplement) solution. The surveyor reviewed the manufacturer's instructions on the bottle of LPS in the presence of LPN#2. After reviewing the manufacturer's instructions, LPN#2 stated that once opened a bottle of LPS solution have a 60-day expiration date. LPN#2 acknowledge that the bottle of LPS solution was undated and that when bottle was opened it should have been dated.
A review of the Manufacturer's Specifications for the following medications revealed the following:
1. Xalatan eye drops once opened have an expiration date of 42-days.
2. Dorzolamide eye drops once opened have an expiration date of 28-days.
3. LPS solution once opened have an expiration date of 60-days.
4. Unopened Xalatan eye drops should have been stored in a refrigerator.
b). On [DATE] at 11:25 AM, the surveyor inspected the 3rd floor medication room refrigerator in the presence of LPN#2. The surveyor observed a narcotic lock box that contained five syringes of Ativan (medication of anxiety) 0.5 mg topical gels. The narcotic box was affixed to the medication refrigerator, but the narcotic box was unlocked.
The surveyor interviewed LPN#2 who acknowledge that the narcotic box was unlocked, and she further stated that it was the facility policy that all narcotics must be double lock.
On [DATE] at 11:35 AM, the surveyor inspected the 2nd floor medication room refrigerator in the presence of LPN#3. The surveyor observed a narcotic lock box that contained twenty-six (26) capsules of Marinol (appetite stimulant) 2.5 mg capsules. The narcotic box was observed affixed to the medication refrigerator, but the narcotic box was unlocked.
The surveyor interviewed LPN#3 who acknowledge that the narcotic box was unlocked, and she further stated that it was the facility policy that all narcotics must be double lock.
c). On [DATE] at 11:35 AM, the surveyor while conducting initial tour observed a 2nd floor medication cart outside of room [ROOM NUMBER], that was left unattended and contained an unused insulin syringe, glucose test strips, blood glucose monitor and a vial of Humalog insulin that were left unsecured on top of the medication cart. The surveyor observed no residents in the vicinity of the medication cart. The surveyor waited for the nurse to returned to the cart which was approximately 4-minutes after the medication cart was observed.
The surveyor interviewed LPN#4 who acknowledge that it was her medication cart. She further acknowledges that she left the cart unattended with medications and medical supplies left in an unsecured area. LPN#2 also stated that it's the facility policy when a medication cart is left unattended that all medications and medical supplies should be left in a lock and secured area.
On [DATE] at 1:00 PM, the surveyor discussed the above concerns with the Administrative team which included the Licensed Nursing Home Administrator (LNHA) and Director of Nursing (DON). There was no additional information provided.
A review of the facility's policy for Medication Storage that was dated [DATE] and provided by the DON that included the following:
2. Any meds that will be expiring should be removed before expiration date. If pending expiration, will determine if supply will be completed before expiration date.
A review of the facility's policy for Controlled Medications Accountability and storage that was dated [DATE] and provided by the DON included the following:
Narcotic ordered for residents are stored in a locked narcotic box of the medication cart. If the narcotic medication is to be refrigerated, the narcotic is stored in the locked box within the refrigerator. The refrigerator has a lock on the door as well.
A review of the facility's policy for Medication Administration and Documentation Policies, Procedures and Information that was dated [DATE] and provided by the DON included the following:
6. The medication cart must be locked when out of nurse's view.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Pharmacy Services
(Tag F0755)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. On 8/30/23 at 11:25 AM, the surveyor inspected the 3rd floor medication room refrigerator in the presence of Licensed Practic...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. On 8/30/23 at 11:25 AM, the surveyor inspected the 3rd floor medication room refrigerator in the presence of Licensed Practical Nurse (LPN#1). The surveyor observed a narcotic lock box that contained five syringes of Ativan (medication of anxiety) 0.5 mg topical gels for Resident #88. The surveyor observed the narcotic box was affixed to the medication refrigerator, but the narcotic box was unlocked.
The surveyor interviewed LPN#2 who acknowledge that the narcotic box was unlocked, and she further stated that it was the facility policy that all narcotics must be double lock.
A review of the admission Record (an admission summary) reflected that the resident was admitted to the facility with diagnoses that included hypertension (elevated blood pressure), anxiety disorder (a mental health disorder characterized by feelings of worry, anxiety, or fear that are strong enough to interfere with one's daily activity), and mood disorder (general emotional state or mood is distorted or inconsistent and interferes with your ability to function).
A review of the Order Summary (OS) (physician's order) dated 3/8/23 revealed a physician order (PO) for Ativan 0.5mg, apply to the inner wrist topically every 8 hours as needed for severe agitation. A further review of the PO revealed that the medication was discontinued on 3/23/23.
A review of the March 2023 electronic Medication Administration Record (eMAR) revealed an order dated 3/8/23, for Ativan 0.5mg (Lorazepam), apply to inner wrist topically every 8 hours as needed for severe agitation with a discontinued date of 3/23/23.
On 3/30/23 at 12:30 PM, the surveyor inspected the 3rd floor medication room refrigerator narcotic box in the presence of LPN#1. LPN#1 acknowledge that the Ativan gel was discontinued and should be remove from active medication and will be destroyed per facility policy.
b). On 8/30/23 at 11:35 AM, the surveyor inspected the 2nd floor medication room refrigerator in the presence of LPN#2. The surveyor observed a narcotic lock box that contained twenty-six (26) capsules of Marinol (appetite stimulant) 2.5 mg capsules for Resident #64. The narcotic box was observed affixed to the medication refrigerator, but the narcotic box was unlocked.
The surveyor interviewed LPN#2 who acknowledge that the narcotic box was unlocked, and she further stated that it was the facility policy that all narcotics must be double lock.
A review of the admission Record reflected that the resident was admitted to the facility with diagnoses that included hypertension (elevated blood pressure), metabolic encephalopathy (chemical imbalance of the brain), and failure to thrive (syndrome of weight loss, decreased appetite and poor nutrition).
A review of the Order Summary Report (OSR) (physician's order) dated 7/17/23 revealed PO for Marinol (Dronabinol) 2.5mg, give 1 capsule by mouth two times a day for appetite stimulant.
A review of the August 2023 eMAR revealed an order dated 07/17/23, for Marinol (Dronabinol) 2.5mg, give 1 capsule by mouth two times a day for appetite stimulant with a discontinued date of 8/18/23.
A review of a Progress Note dated 8/18/23 at 5:10 PM revealed that Resident #64 was discharged home.
On 3/30/23 at 12:30 PM, the surveyor inspected the 2nd floor medication room refrigerator narcotic box in the presence of LPN#2. LPN#2 acknowledge that the Marinol 2.5 mg belonged to Resident #64 and that the resident was discharged from the facility. The surveyor observed LPN#2 place the Marinol back in the narcotic box and then lock the box. LPN#2 stated that she will destroy the medication during shift change because she will need another nurse to witness the destruction.
On 8/31/23 at 1:00 PM, the surveyor discussed the above concerns with the Administrative team which included the Licensed Nursing Home Administrator (LNHA) and Director of Nursing (DON). There was no additional information provided.
A review of the facility's policy for Controlled Medications Accountability and storage that was dated 01/07/23 and was provided by the DON included the following:
Narcotic ordered for residents are stored in a locked narcotic box of the medication cart. If the narcotic medication is to be refrigerated, the narcotic is stored in the locked box within the refrigerator. The refrigerator has a lock on the door as well.
A review of the facility's policy Medication Storage that was dated 05/26/23 and was provided by the DON included the following:
4. Any discontinued medications should be removed from the refrigerator, med room or med cart and returned to pharmacy or discarded no later than 14 days.
A review of the facility's policy Discarding and Destroying Medications that was undated and was provided by the DON revealed the following:
5 (c). Disposal of controlled substances must take place immediately (no longer than three days) after discontinuation of use by a resident.
NJAC 8:39-11.2 (b), 29.2(a), 29.2 (d), 29.3(a)(5), 29.4(g)
Based on observation, interview and record review, it was determined that the facility failed to provide pharmaceutical services in accordance with professional standards to a.) accurately obtain a blood pressure and accurately document the site, b.) accurately document the refusal of medications, d.) dispose of medications in a safe manner, c.) clarify and accurately administer a medication (Midodrine) according to a physician's order and d.) remove and dispose of controlled substances from active inventory when discontinued from March of 2023 until surveyor inquiry. The deficient practices occurred for two (2) of seven (7) residents, (Resident #56 and #75) reviewed for medication management and for two (2) of two (2) medication refrigerators inspected.
Reference: New Jersey Statutes Annotated, Title 45. Chapter 11. Nursing Board. The Nurse Practice Act for the State of New Jersey states: The practice of nursing as a registered professional nurse is defined as diagnosing and treating human responses to actual and potential physical and emotional health problems, through such services as case finding, health teaching, health counseling, and provision of care supportive to or restorative of life and wellbeing, and executing medical regimens as prescribed by a licensed or otherwise legally authorized physician or dentist.
Reference: New Jersey Statutes Annotated, Title 45, Chapter 11. Nursing Board. The Nurse Practice Act for the State of New Jersey states: The practice of nursing as a licensed practical nurse is defined as performing tasks and responsibilities within the framework of case finding; reinforcing the patient and family teaching program through health teaching, health counseling and provision of supportive and restorative care, under the direction of a registered nurse or licensed or otherwise legally authorized physician or dentist.
This deficiency was evidenced by the following:
1. On 8/30/23 at 8:00 AM, during the morning medication pass, the surveyor observed the Licensed Practical Nurse (LPN #1) obtaining a blood pressure (BP) for Resident #56. The LPN#1 placed the BP cuff on the resident's right leg below the knee. The LPN #1 stated that this was the best way to obtain the BP because the resident was very thin. The LNP#1 then stated that she received an error indication on the digital BP machine, the surveyor observed her reposition the BP cuff on the same area and immediately restarted the BP machine. The LNP#1 then stated that she had obtained a BP of 187/147 and a heart rate (HR) of 63. The LPN#1 added that the resident's BP was usually high and would check the BP again later.
After removing the BP cuff, the LPN#1 asked the resident if he/she wanted the Iron pill and the resident shook their head in the yes direction. The LNP#1 explained to the surveyor that the resident did not always like the Iron pill because it turned the applesauce black and would refuse to take it.
On 8/30/23 at 8:07 AM, the surveyor observed the LPN#1 preparing five (5) medications which included one (1) 100 MG tablet of Metoprolol Tartrate (Lopressor)(a medication used to treat high blood pressure), for Resident #56.
On 8/30/23 at 8:16 AM, upon returning to the medication cart, the LPN #1 indicated on the EMAR the BP of 187/147 was obtained in the sitting position to the right arm. The LPN#1 stated she had not seen another way to enter the site the BP was taken.
The surveyor reviewed the medical record for Resident #56.
A review of the resident's admission Record (AR) revealed diagnoses which included dysphagia (difficulty swallowing), aphasia (difficulty speaking), hypertension (HTN)(high blood pressure).
A review of the quarterly Minimum Data Set (MDS), an assessment tool used to facilitate the management of care, with an assessment reference date of 7/14/2023, reflected the resident had a brief interview for mental status (BIMS) score of zero (0) out of 15, indicating that the resident had a severely impaired cognition.
A review of the Order Summary Report revealed physician orders (PO) dated 7/25/23 for Metoprolol Tartrate oral tablet 100 MG, give one tablet by mouth two times a day for HTN-give with food hold if systolic BP less than 110 millimeter of mercury (mmhg) and HR less than 60.
A review of the vital sign recordings for BP for August 2023 had the following dates which indicated the site for the BP was other; 8/3/23 at 7:14 PM, 8/4/23 at 8:43 AM, and 8/8/23 at 8:01 AM. All other entries for the site of the BP were to the right or left arm.
A review of the August EMAR reflected the above PO and revealed that the vital sign recordings for 8/4/23 and 8/8/23 were entered by LPN#1.
On 8/30/23 at 12:13 PM, the surveyor interviewed the Director of Nursing (DON) who stated that the Infection Preventionist (IP) and Assistant Director of Nursing (ADON) were the staff educators for medication pass.
On 8/30/23 at 1:08 PM, the surveyor interviewed the Unit Manager (UM)/LPN who stated that she was familiar with Resident #56 but had not taken a BP on the resident's leg. The UM/LPN could not speak to if that was the correct method because she had not taken the BP that way. The UM/LPN stated that a BP of 187/147 had not sounded accurate and would retake the BP to be sure. The UM/LPN added that when she would retake the BP that she would change the arm in order to get an accurate reading. The UM/LPN also stated that she used her own digital BP machine because there was only one BP machine on the unit and there were two nurses who would be administering medications at the same time, so it was easier to use her own. At that time, the UM/LPN was unable to locate the facility BP machine that was on the unit.
On 8/31/23 at 9:30 AM, the surveyor interviewed the IP who stated that she was employed at the facility approximately less than two (2) months and could speak to medication pass techniques because she helped with orientation and educating the nurses on medication pass techniques. The IP stated that a BP of 187/147 had not sounded accurate and would recommend retaking the BP and if the BP was accurate than the physician should be called. The IP explained that if an error or inaccurate reading of a BP was obtained then the nurse should retake the BP. The IP further explained that retaking a BP would mean changing the site such as going from right to left arm or if the same site was going to be used again then the nurse would have to wait at least five (5) minutes because retaking the BP on the same site could give an inaccurate reading. The IP stated that she would prefer the nurses using the facility BP machines because they were calibrated and remained in the facility. The IP further stated that when nurses used their own BP machines there was the possibility that they were not always calibrated and accurate. The IP also stated that she knew there was one BP machine on each unit and that there were additional BP machines that were being purchased.
On 8/31/23 at 11:30 AM, the IP provided the surveyor with a Medication Pass Audit Tool dated 5/2/23 for LPN #1 completed by the Consultant Pharmacist (CP) which revealed that there were areas indicating a No, which meant that a technique was not performed appropriately.
On 8/31/23 at 2:07 PM, the survey team met with the Licensed Nursing Home Administrator (LNHA), DON, ADON and IP. The IP stated that when a medication pass audit was performed if there were indications that proper procedures were not followed then another observation and in servicing would be followed up. The DON stated that she would check if there were any other medication observations performed for LPN #1.
On 9/1/23 at 8:58 AM, the DON provided the surveyor with an In-service on medication pass dated 5/10/23 completed by the ADON and signed by LPN #1 was performed and a Competency Validation: Medication Pass was completed by the ADON on 7/26/23 that indicated the LPN#1 Meets Standard for all the Performance Criteria. In addition, the DON provided a Medication Observation Form dated 6/9/23 for LPN #1 completed by the provider pharmacy which revealed that there was zero (0) % error rate.
On 9/1/23 at 9:38 AM, the surveyor interviewed the Consultant Pharmacist (CP) via telephone who stated that she had been the consultant for the facility for approximately a year. The CP stated that she had performed medication observations with the nurses and verified that she used a Medication Pass Audit Tool but was unable to speak to the actual form that she had completed for LPN#1. The CP stated that she would add to the form Discussed tips & tricks for med pass observation by Department of Health (DOH), etc. because as she performed the medication observation, she would review different areas to help the nurses understand what the correct procedure that should be done during the medication pass. The CP added that the completed Medication Pass Audit Tool was left with the DON and if there were issues, she would review them, and the DON would decide the next step.
A review of the facility policy dated as reviewed 6/22/23 for Medication Administration and Documentation provided by the DON reflected that It is the policy of this facility to ensure that Medication Administration and Documentation occurs in a timely and accurate manner. In addition, The EMAR is the form onto which all medication orders are transcribed from physician electronic orders, from which medications are poured and administered and on which medication doses are documented.
A review of the facility policy dated as reviewed 3/1/23 for Vital Signs provided by the DON reflected that Vital signs are documented in the medical records. Vital signs can be taken manually or obtained electronically. Physician's or Nurse Practitioner's should be notified about changes in vital signs including any symptoms identified, in accordance with parameters ordered.
2. On 8/30/23 at 8:05 AM, during the morning medication pass, the LPN#1 asked the resident if he/she wanted the Iron pill and the resident shook their head in the yes direction. The LNP#1 explained to the surveyor that the resident did not always like the Iron pill because it turned the applesauce black and would refuse to take it.
On 8/30/23 at 8:07 AM, the surveyor observed the LPN#1 preparing five (5) medications which included one (1) 20 milligram (MG) tablet of Famotidine (Pepcid) (a medication used to treat excess stomach acid), one (1) 100 MG tablet of Metoprolol Tartrate (Lopressor)(a medication used to treat high blood pressure), one (1) 150 MG capsule of Polysaccharide-Iron Complex (Ferrex)(a medication used to treat iron deficiency), one (1) 500 MG tablet of Ascorbic Acid (Vitamin C)(a supplement) and two (2) 325 MG tablets of Acetaminophen (Tylenol)(a medication used for pain relief) for Resident #56.
On 8/30/23 at 8:14 AM, the surveyor observed the LPN #1 crush four (4) of the five (5) medications together in a pouch and then poured the crushed medications into a 30 milliliter (ML) medication cup with applesauce. The LPN#1 then opened the Ferrex capsule and mixed the contents into the medication cup that had the four (4) medications and filled the medication cup with applesauce. The applesauce then turned a black color.
On 8/30/23 at 8:16 AM, the surveyor observed the LPN#1 approach the resident to administer the five (5) medications in the applesauce and the resident was shaking their head in the no direction. The LPN #1 explained that the applesauce contained the resident's medication and that it was important to take the medications. The LPN#1 scooped a spoonful of the applesauce and administered the spoonful to the resident. The resident took the spoonful and shook their head in the no direction repeatedly. The LPN#1 explained again the importance and told the resident there was just another spoonful left. The LPN#1 was unable to administer the remaining applesauce containing the medications.
Upon returning to the medication cart, the LPN#1 discarded the remaining applesauce and stated that the resident had swallowed more than half of the applesauce, so she felt that the resident had received the medications. The LPN#1 then indicated on the electronic administration record (EMAR) that the resident had received the five (5) medications. The LPN#1 had not documented any refusal of medication by the resident.
The surveyor reviewed the medical record for Resident #56.
A review of the resident's admission Record (AR) revealed diagnoses which included dysphagia (difficulty swallowing), aphasia (difficulty speaking), hypertension (HTN)(high blood pressure), severe protein-calorie malnutrition and gastro-esophageal reflux disease (acid reflux).
A review of the quarterly Minimum Data Set (MDS), an assessment tool used to facilitate the management of care, with an assessment reference date of 7/14/2023, reflected the resident had a brief interview for mental status (BIMS) score of zero (0) out of 15, indicating that the resident had a severely impaired cognition.
A review of the Order Summary Report revealed physician orders (PO) for the following:
Famotidine tablet 20 MG, give 1 tablet by mouth in the morning for acid indigestion with a start date 1/13/23.
Metoprolol Tartrate oral tablet 100 MG, give one tablet by mouth two times a day for HTN-give with food hold if systolic BP less than 110 millimeter of mercury (mmhg) and HR less than 60 with a start date of 7/25/23.
Polysaccharide Iron Complex capsule 150 MG, give 1 capsule by mouth one time a day for deficiency with a start date of 1/13/23.
Ascorbic Acid tablet 500 MG, give 1 tablet by mouth one time a day for supplement with a start date of 1/13/23.
Acetaminophen tablet 325 MG, give 2 tablet by mouth every 6 hours as needed for pain with a start date of 2/24/23.
A review of the August 2023 EMAR revealed consistency with the above POs. In addition, the EMAR had not revealed any refusals by the resident for medications.
A review of the resident's progress notes had not indicated that there were any refusals of medications.
A review of the resident's Interdisciplinary Care Plan had not revealed that there was a Focus area for the resident refusing medications.
On 8/30/23 at 12:13 PM, the surveyor interviewed the Director of Nursing (DON) who stated that the Infection Preventionist (IP) and Assistant Director of Nursing (ADON) were the staff educators for medication pass.
On 8/30/23 at 1:08 PM, the surveyor interviewed the Unit Manager (UM)/LPN who stated that she was familiar with Resident #56 and was unaware of any medication refusals. The UM/LPN stated that when a resident refused medications the physician would be notified and there would be documentation in the progress notes.
On 8/31/23 at 9:30 AM, the surveyor interviewed the IP who stated that she was employed at the facility approximately less than two (2) months and could speak to medication pass techniques because she helped with orientation and educating the nurses on medication pass techniques. The IP stated that the nurses would have to document that a medication was refused because the whole dose would not have been administered and the physician should be notified. The IP also stated that the nurses should try to figure out why the resident was refusing medications and put interventions in place such as changing the medication if the taste were an issue or possibly changing the time.
In addition, the IP provided the surveyor with a Medication Pass Audit Tool dated 5/2/23 for LPN #1 completed by the Consultant Pharmacist (CP) which revealed that there were areas indicating a No, which meant that the technique was not performed appropriately.
On 8/31/23 at 2:07 PM, the survey team met with the Licensed Nursing Home Administrator (LNHA), DON, ADON and IP. The IP stated that when a medication pass audit was performed if there were indications that proper procedures were not followed then another observation and in servicing would be followed up. The DON stated that she would check if there were any other medication observations performed for LPN #1.
On 9/1/23 at 8:58 AM, the DON provided the surveyor with an In-service on medication pass dated 5/10/23 completed by the ADON and signed by LPN #1 was performed and a Competency Validation: Medication Pass was completed by the ADON on 7/26/23 that indicated the LPN#1 Meets Standard for all the Performance Criteria. In addition, the DON provided a Medication Observation Form dated 6/9/23 for LPN #1 completed by the provider pharmacy which revealed that there was zero (0) % error rate.
On 9/1/23 at 9:38 AM, the surveyor interviewed the Consultant Pharmacist (CP) via telephone who stated that she had been the consultant for the facility for approximately a year. The CP stated that she had performed medication observations with the nurses and verified that she used a Medication Pass Audit Tool but was unable to speak to the actual form that she had completed for LPN#1. The CP stated that she would add to the form Discussed tips & tricks for med pass observation by Department of Health (DOH), etc. because as she performed the medication observation, she would review different areas to help the nurses understand what the correct procedure that should be done during the medication pass. The CP added that if a resident was refusing a medication or was unable to receive the entire dose then the physician should be notified, and the nurses should review the possible reason the resident was refusing to possibly make a change. The CP added that the completed Medication Pass Audit Tool was left with the DON and if there were issues, she would review them, and the DON would decide the next step.
A review of the facility policy dated as reviewed 6/22/23 for Medication Administration and Documentation provided by the DON reflected that Documents administration of medication in the EMAR immediately following administration. Notes in EMAR medications not administered (i.e., refused, etc.) and identifies reason. The policy also reflected that Documents all held or refused medications on EMAR. Uses prudent professional judgement by informing Physician in a timely manner when medications held, refused, or otherwise unavailable for administration.
3. On 8/30/23 at 8:07 AM, during the morning medication pass, the surveyor observed the LPN#1 preparing five (5) medications which included one (1) 20 milligram (MG) tablet of Famotidine (Pepcid) (a medication used to treat excess stomach acid), one (1) 100 MG tablet of Metoprolol Tartrate (Lopressor)(a medication used to treat high blood pressure), one (1) 150 MG capsule of Polysaccharide-Iron Complex (Ferrex)(a medication used to treat iron deficiency), one (1) 500 MG tablet of Ascorbic Acid (Vitamin C)(a supplement) and two (2) 325 MG tablets of Acetaminophen (Tylenol)(a medication used for pain relief) for Resident #56.
On 8/30/23 at 8:14 AM, the surveyor observed the LPN #1 crush four (4) of the five (5) medications together in a pouch and then poured the crushed medications into a 30 milliliter (ML) medication cup with applesauce. The LPN#1 then opened the Ferrex capsule and mixed the contents into the medication cup that had the four (4) medications and filled the medication cup with applesauce. The applesauce then turned a black color.
On 8/30/23 at 8:16 AM, the surveyor observed the LPN#1 approach the resident to administer the five (5) medications in the applesauce and the resident was shaking their head in the no direction. The LPN #1 explained that the applesauce contained the resident's medication and that it was important to take the medications. The LPN#1 scooped a spoonful of the applesauce and administered the spoonful to the resident. The resident took the spoonful and shook their head in the no direction repeatedly. The LPN#1 explained again the importance and told the resident there was just another spoonful left. The LPN#1 was unable to administer the remaining applesauce containing the medications.
Upon returning to the medication cart, the LPN#1 discarded the remaining applesauce in the garbage that was attached to the medication cart.
On 8/30/23 at 12:13 PM, the surveyor interviewed the Director of Nursing (DON) who stated that the Infection Preventionist (IP) and Assistant Director of Nursing (ADON) were the staff educators for medication pass.
On 8/30/23 at 1:08 PM, the surveyor interviewed the Unit Manager (UM)/LPN who stated that when any medication had to be disposed there was a medication disposal system on each medication cart. The UM/LPN added that if the medication were a controlled medication, then the DON or ADON would be given the controlled medication for a witnessed destruction. The surveyor with the UM/LPN looked in the medication cart that the UM/LPN was using and were unable to find the medication disposal system in that medication cart. The UM/LPN stated that she would have to get one for the cart.
On 8/30/23 at 1:16 PM, the LPN#1 showed the surveyor that she had a medication disposal system on the medication cart that she was using. The LPN #1 stated that because the medications were crushed for Resident #56, she could throw them in the garbage that was attached to the medication cart.
On 8/31/23 at 9:30 AM, the surveyor interviewed the IP who stated that she was employed at the facility approximately less than two (2) months and could speak to medication pass techniques because she helped with orientation and educating the nurses on medication pass techniques. The IP stated that when the nurses had to dispose of a medication that was not a controlled medication then they would use the medication disposal system that was on each cart. The IP further explained that the safest method for medication disposal even if the medications were crushed was to use the medication disposal system.
On 9/1/23 at 9:38 AM, the surveyor interviewed the CP via the telephone who stated that the nurses were to use the medication disposal system when a medication needed to be discarded. The CP added that even if the medication was crushed that the medication disposal system should be used and thought there was one on each medication cart.
A review of the undated facility policy for Discarding and Destroying Medications provided by the DON reflected that Non-controlled and Schedule V (non-hazardous) controlled substances will be disposed of in accordance with state regulations and federal guidelines regarding disposition of non-hazardous medications.
4. On 8/28/23 at 11:42 AM the surveyor observed Resident #75 in bed, the surveyor attempted to interview the resident, but the resident was unable to answer any questions.
The surveyor reviewed the medical record for Resident #75.
A review of the resident's AR revealed diagnoses which included dementia, neurocognitive disorder with [NAME] bodies (a mental health disorder that primarily affect cognitive abilities), syncope and collapse and HTN.
A review of the admission MDS, an assessment tool used to facilitate the management of care, with an assessment reference date of 8/30/2023, reflected the resident had a BIMS score of zero (0) out of 15, indicating that the resident had a severely impaired cognition.
A review of the August and September electronic medication records (EMAR) revealed a PO dated 8/23/23 for Midodrine Hydrochloride oral tablet 5 MG, give 5 MG by mouth every 8 hours (Q8H) as needed (PRN) for low BP, give if BP less than 110. There was no documentation that the medication was administered.
A review of the vital sign recordings for the resident's BP for August 2023 had the following dates with BP recordings that had a BP less than 110; on 8/29/23 at 5:26 PM 82/52, on 8/30/23 at 7:47 PM 107/70 and on 9/1/23 at 10:40 AM 107/60.
Further review of the August and September EMARs revealed a PO dated 8/24/23 for Metoprolol Tartrate (Lopressor) (a medication used to slow the heart rate and lower BP). oral tablet 25 MG, give 25 MG by mouth two times a day for HTN hold for systolic BP less than 110 or HR less than 60. There was documentation on 8/29/23 that the BP was 82/52 and on 8/30/23 the BP was 107/70 and the Lopressor medication was held. There was documentation on 9/1/23 that the Lopressor medication was held but no documentation of the BP results.
On 9/5/23 at 11:23 AM, the surveyor interviewed LPN #2 who stated that she was the medication nurse for Resident #75. The LPN #2 stated that the resident had been readmitted at the end of August. The surveyor with the LPN#2 reviewed the EMAR regarding the PRN Midodrine and the LPN#2 stated that if the resident's BP was less than 110 then the Midodrine should have been administered. The LPN#2 stated that she had not administered the Midodrine because she had not had a BP less than 110 for the resident. The LPN#2 acknowledged that the PRN Midodrine had no documentation as being administered and also acknowledged that there was documentation of BP's less than 110. The LPN#2 also stated that the resident had no PO for a BP to be obtained every 8 hours (Q8H) and that a BP was obtained twice a day for the medication Lopressor.
On 9/6/23 at 9:49 AM, the surveyor interviewed the DON who stated that she thought the PO for Midodrine was a PRN PO and was allowed to be administered three times within a 24-hour period and that a BP was not needed Q8H.
On 9/6/23 at 10:05 AM, the surveyor further interviewed the DON. The surveyor with the DON reviewed the EMAR for Resident #75. The DON acknowledged that the Midodrine was not administered when the BP was less than 110. The DON also acknowledged that when the BP was taken for the Lopressor PO and was less than 110, the Lopressor was held but there was no indication to administer the PRN Midodrine. The DON acknowledged that the PO for PRN Midodrine should be clarified.
A review of the facility policy dated as reviewed 6/22/23 for Medication Administration and Documentation provided by the DON reflected that It is the policy of this facility to ensure that Medication Administration and Documentation occurs in a timely and accurate manner. In addition, the policy reflected, Monitors vital signs when appropriate prior to medication administration. Administers med according to parameters ordered by physician (if any).